Strategic Synergy Leverage the Bristol Myers Squibb merger to position targeted collaboration opportunities in oncology and serious disease areas, offering integrated solutions that align with the combined company’s expanded pipeline and global reach.

Enterprise Analytics Highlight value of advanced data and integration capabilities using the tech stack (Snowplow, Power BI, Boomi) to optimize R&D analytics, supply chain visibility, and pharmacovigilance for streamlined operations and faster time-to-market.

Operational Scale Position scalable manufacturing and IT infrastructure partnerships that support the merged entity’s broad product portfolio, leveraging ERP and automation tools to improve efficiency, compliance, and traceability across regions.

Capitalize Earnings Target discussions around cost optimization, revenue expansion, and capital-efficient product launches aligned with the company’s reported revenue range, emphasizing measurable ROI from technology and process improvements.

Market Leadership Offer competitive intelligence and market trend services to support a leadership position in biopharma, including benchmarking, clinical trial analytics, and customer engagement solutions tailored to large pharma enterprise needs.